NEW YORK (TheStreet) -- CHANGE IN RATINGS
Accenture (ACN) was upgraded at Societe Generale to hold from sell. $75 price target. Estimates were also boosted, given an improvement in Europe.
Ariad Pharma (ARIA) was upgraded at Oppenheimer to outperform from perform. $24 price target. Company has a solid pipeline, which should drive near-term growth, Oppenheimer said.
Colgate-Palmolive (CL) was upgraded at Morgan Stanley to overweight. $68 price target. Company can generate above-average sales growth and deserves a higher multiple, Morgan Stanley said.Chipotle (CMG) was upgraded at Morgan Stanley to overweight. $485 price target. Company can continue to raise prices, Morgan Stanley said.
(JCI) was downgraded at Morgan Stanley to underweight from overweight. Valuation call, based on a $40 price target, Morgan Stanley said. JC Penney (JCP) was downgraded at Maxim Group to hold from buy. Company is seeing lower sales and rising debt, Maxim Group said. Marathon Oil (MRO) was upgraded at Argus to buy from hold. $42 price target. Company is leveraged to higher oil prices, Argus said. Estimates also boosted.
(PNRA) was downgraded at Morgan Stanley to equal-weight. Company may struggle to raise prices, Morgan Stanley said. Whitewave Foods (WWAV) was downgraded at BMO Capital to underperform. $17 price target. Sales growth will likely decelerate in the coming years, BMO Capital said. Xilinx (XLNX) was upgraded at Pacific Crest to outperform from sector perform. $55 price target. Company should benefit from the LTE upgrade in China, Pacific Crest said.
STOCK COMMENTS / EPS CHANGESAmetek (AME) price target was raised at Jefferies was increased to $53. Sales are improving, and there is significant M&A potential in the fourth quarter, Jefferies said. Buy rating. Yahoo! (YHOO) price target was raised at Bank of America/Merrill Lynch. Shares are now seen reaching $38. Alibaba IPO should create value, BofA/Merrill said. >To submit a news tip, email: email@example.com. Follow TheStreet on Twitter and become a fan on Facebook.
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV